Evaluation of 9 biomarkers for predicting 10-year cardiovascular risk in patients undergoing coronary angiography: Findings from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2609-2615

  Ó Hartaigh, Bríain ^a,b   Thomas, G Neil ^b,c   Bosch, Jos A ^b,c,d   Hemming, Karla ^b   Pilz, Stefan ^c,e   Loerbroks, Adrian ⁱ   Kleber, Marcus E ^c,f   Grammer, Tanja B ^c   Fischer, Joachim E ^c   Silbernagel, Guenther ^g   Tomaschitz, Andreas ⁱ   März, Winfried ^c,e,h  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f UNIVERSITY HOSPITAL ULM   (Germany)

^g UNIVERSITY OF BERN   (Switzerland)

^h SYNLAB ACADEMY   (Germany)

ⁱ Department of Orthopedic Surgery   (Germany)

Author keywords

Biomarker; Cardiovascular; Discrimination; Reclassification; Risk factor

Indexed keywords

25 HYDROXYVITAMIN D; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMYLOID A PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; ADOLESCENT; BLOOD; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; TIME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84885648355     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.043     Document Type: Article

References (38)

1. N.R. Cook, and P.M. Ridker Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures Ann Intern Med 150 2009 795 802
2. P. Greenland, and P.G. O'Malley When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk Arch Intern Med 165 2005 2454 2456
3. B. Zethelius, L. Berglund, and J. Sundstrom Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
4. J.C. Kaski, D.J. Fernandez-Berges, and L. Consuegra-Sanchez A comparative study of biomarkers for risk prediction in acute coronary syndrome - results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study Atherosclerosis 212 2010 636 643
5. B.R. Winkelmann, W. Marz, and B.O. Boehm Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease Pharmacogenomics 2 2001 S1 S73
6. Summary of revisions for the 2010 clinical practice recommendations Diabetes Care 33 2010 S3
7. D.W.J. Hosmer, and S. Lemeshow Applied logistic regression 2000 John Wiley New York
8. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 [discussion 207-12]
9. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
10. O. Ozdemir, F. Gundogdu, and S. Karakelleoglu Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris Coron Artery Dis 19 2008 15 19
11. E. Lindmark, E. Diderholm, L. Wallentin, and A. Siegbahn Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy JAMA 286 2001 2107 2113
12. R. Dragu, S. Huri, and R. Zuckerman Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction Atherosclerosis 196 2008 405 412
13. B.D. Horne, J.L. Anderson, and J.M. John Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45 2005 1638 1643
14. A.O. Spiel, J.C. Gilbert, and B. Jilma von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes Circulation 117 2008 1449 1459
15. S.G. Thompson, J. Kienast, S.D. Pyke, F. Haverkate, and J.C. van de Loo Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group N Engl J Med 332 1995 635 641
16. J.H. Jansson, T.K. Nilsson, and O. Johnson von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death Br Heart J 66 1991 351 355
17. L.C. Liu, A.A. Voors, and D.J. van Veldhuisen Vitamin D status and outcomes in heart failure patients Eur J Heart Fail 13 2011 619 625
18. H. Dobnig, S. Pilz, and H. Scharnagl Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality Arch Intern Med 168 2008 1340 1349
19. E. Zakynthinos, and N. Pappa Inflammatory biomarkers in coronary artery disease J Cardiol 53 2009 317 333
20. B. Schieffer, E. Schieffer, and D. Hilfiker-Kleiner Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability Circulation 101 2000 1372 1378
21. J.N. Wilcox, N.A. Nelken, S.R. Coughlin, D. Gordon, and T.J. Schall Local expression of inflammatory cytokines in human atherosclerotic plaques J Atheroscler Thromb 1 1994 S10 S13
22. P. Biswas, F. Delfanti, and S. Bernasconi Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line Blood 91 1998 258 265
23. A. Zernecke, I. Bot, and Y. Djalali-Talab Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis Circ Res 102 2008 209 217
24. J. Sainz, and M. Sata Open sesame! CXCR4 blockade recruits neutrophils into the plaque Circ Res 102 2008 154 156
25. M. Madjid, I. Awan, J.T. Willerson, and S.W. Casscells Leukocyte count and coronary heart disease: implications for risk assessment J Am Coll Cardiol 44 2004 1945 1956
26. C. Weber, A. Zernecke, and P. Libby The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models Nat Rev Immunol 8 2008 802 815
27. Z.M. Ruggeri, and J. Ware von Willebrand factor FASEB J 7 1993 308 316
28. G.N. Thomas, B. O Hartaigh, and J.A. Bosch Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study Diabetes Care 35 2012 1158 1164
29. S. Pilz, W. Marz, and B. Wellnitz Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography J Clin Endocrinol Metab 93 2008 3927 3935
30. K.A. Nibbelink, D.X. Tishkoff, S.D. Hershey, A. Rahman, and R.U. Simpson 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte J Steroid Biochem Mol Biol 103 2007 533 537
31. N. Bodyak, J.C. Ayus, and S. Achinger Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals Proc Natl Acad Sci U S A 104 2007 16810 16815
32. J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
33. A.R. Tall C-reactive protein reassessed N Engl J Med 350 2004 1450 1452
34. P.W. Wilson, B.H. Nam, and M. Pencina C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study Arch Intern Med 165 2005 2473 2478
35. S. Blankenberg, T. Zeller, and O. Saarela Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project Circulation 121 2010 2388 2397
36. T.J. Wang, P. Gona, and M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639
37. H.C. Kim, P. Greenland, and J.E. Rossouw Multimarker prediction of coronary heart disease risk: the Women's Health Initiative J Am Coll Cardiol 55 2010 2080 2091
38. M.A. Hlatky, P. Greenland, and D.K. Arnett Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416